Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Biogen Inc. Faces Analyst Downgrades, but Market Remains Cool on Earnings

December 27, 2024
Biogen Inc. (NASDAQ:BIIB) recently announced its earnings report, which has resulted in a cool response from the market. Despite the company's efforts and achievements, the market has shown limited enthusiasm for the financial results.
Notably, Biogen Inc. has seen its shares being purchased by Principal Financial Group Inc. (NASDAQ:BIIB), indicating some investor confidence in the company's future prospects. This move by Principal Financial Group Inc. reflects their trust in Biogen's ability to deliver long-term growth and profitability.
However, it is important to note that Biogen Inc. has also faced multiple analyst downgrades in December 2024. This could potentially impact investor sentiment and future investment decisions. Analysts' opinions play a significant role in shaping market perceptions and influencing stock movement.
Looking ahead, options trading for Biogen Inc. in February 2025 has caught the attention of investors. The first week of BIIB February 2025 options trading has already begun, indicating the market's anticipation of potential volatility and opportunities associated with the company.
As an investor, it is crucial to make informed decisions. Seeking advice from professionals, such as Stocks Prognosis, can provide valuable insights and assistance in predicting the future movement of Biogen Inc.'s shares. Consider seeking their expertise to maximize your investment potential.
If you want to leave a comment, then you need Login or Register





Other data for BIIB

Related data

BIIBSeptember 11, 2025Biogen Inc. Stock Price Target Forecast Achieved with 12.88% Profit  ~1 min.

Biogen Inc. (BIIB) investors celebrated as the stock hit the long forecasted price target of 148.84 $ on September 11, 2025, marking a profitable outcome of 12....


BIIBSeptember 11, 2025Biogen Inc. Hits Price Target Forecast with 14.68% Profit  ~1 min.

Amidst recent market volatility, Biogen Inc. has successfully achieved the price target forecast set by QuantWave, resulting in a substantial profit of 14.68%....


BIIBSeptember 11, 2025QuantWave Achieves 14.18% Profit on Biogen Inc. Stock Price Target Forecast  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for Biogen Inc., resulting in a profitable return of 14.18%....


BIIBSeptember 11, 2025Biogen Inc. Stock Price Reaches Forecast Target with 11.82% Profit - QuantWave Success  ~2 min.

Biogen Inc. (NASDAQ: BIIB) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 11.82%. The forecast signal was issued on July 14, 2025, with a price of $133....


BIIBSeptember 11, 2025Biogen Inc. Stock Hits Price Target Forecast on QuantWave, Generating 9.98% Profit  ~1 min.

Biogen Inc. investors rejoice as the stock hits the price target forecast set by QuantWave, yielding a profitable return of 9.98%. The forecast signal was initiated on July 10, 2025, with a price of $135....


BIIBSeptember 11, 2025Biogen Inc. Stock Hits Price Target Forecast with 13.92% Profit Gain  ~1 min.

Biogen Inc. has achieved the price target forecast set by QuantWave, signaling a long position on June 13th when the stock was at 130.65 $. The target price of 148....


BIIBSeptember 9, 2025Biogen Inc. Stock Forecast Hits Target with 9.58% Profit - QuantWave Achieves Success in Predictive Analytics  ~1 min.

Biogen Inc. stock has recently achieved a significant price target forecast, as predicted by QuantWave's automated forecasting platform. The forecast signal was given on June 16, 2025, with a price of $131....


BIIBSeptember 9, 2025Biogen Inc. Stock Hits Price Target Forecast, Generating 10.35% Profit for Investors  ~1 min.

Biogen Inc. has successfully achieved the price target forecast set by QuantWave, indicating a profitable opportunity for investors who followed the prediction....


BIIBSeptember 3, 2025Biogen Inc. Stock Hits Price Target Forecast for 11.9% Profit: A Success for QuantWave Analytics  ~1 min.

Biogen Inc. stock recently achieved a price target forecast set by QuantWave, resulting in a profit of 11.9%. The forecast signal was given on June 17, 2025, with the stock priced at $126....


BIIBAugust 24, 2025AIA Group Ltd Makes New 663000 Investment in Biogen Inc. NASDAQ:BIIB  ~1 min.

AIA Group Ltd has recently made a significant investment in Biogen Inc., acquiring 663000 shares on the NASDAQ....


BIIBDecember 15, 2024Inspire Trust Co. N.A. Grows Stock Holdings in Biogen Inc. NASDAQ:BIIB  ~1 min.

Recently, Inspire Trust Co. N.A. has increased its stock holdings in Biogen Inc. (NASDAQ:BIIB), expressing its confidence in the company's future prospects. Biogen Inc....


BIIBJanuary 22, 2025Short Interest in Biogen Inc. NASDAQ:BIIB Increases By 42.6  ~2 min.

Biogen Inc. (NASDAQ:BIIB), a leading biotechnology company, has witnessed a significant increase in short interest by 42.6%....


CSXJanuary 1, 2025CSX Corporation: Hedge Funds Show Positive Sentiment Towards This Logistics Stock  ~1 min.

In recent news, hedge funds have shown bullish sentiment towards CSX Corporation, a leading logistics company....


BIIBFebruary 26, 2025Biogen Inc. BIIB: Innovative Pharmaceutical Stock with Promising Growth Potential  ~2 min.

Biogen Inc. (NASDAQ:BIIB) is being recognized as one of the cheap pharmaceutical stocks to buy, according to analysts at Yahoo Finance....


BIIBDecember 9, 2024Biogen Inc. Faces Setbacks in Pipeline and Leqembi Sales  ~2 min.

Fmr LLC, a renowned investment firm, has recently divested 229,202 shares of Biogen Inc. (NASDAQ:BIIB), thereby reducing its stake in the company. This move comes as Biogen Inc....